Peptide discovery and development at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

40 organizations at PepTalk 2027 present work in peptide discovery and development: 15 drug developers, 15 academic, government and non-profit bodies and 10 suppliers and service providers. Between them they bring 91 presentations to the program. Most represented: Genentech (10 on the program), Merck & Co. (8 on the program), Eli Lilly (5 on the program). As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–7 of 40 organizations

Organization	PepTalk 2027 Attendance
Genentech South San Francisco, CA
gene.com Large pharma Roche Group biotechnology company discovering and developing antibody, peptide and other protein medicines.	Talk Mon Jan 18 10:00am–10:30am A Machine-Learning–Enabled Venom Peptide Platform for Rapid Drug Discovery SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Development of LRRC15-Binding Disulfide-Constrained Peptides for PET Imaging of Cancer-Associated Fibroblasts SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Talk Mon Jan 18 4:00pm–4:30pm Mirror-Image mRNA Display Uncovers Isoform-Selective D-Peptide Macrocycles Targeting a Cryptic KRAS Pocket SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Panel Mon Jan 18 4:30pm–5:00pm Breaking Down Silos—Integrating Disciplines to Accelerate Peptide Drug Discovery SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact · with EPOC Scientific, University of Florida, University of Queensland +1 more Talk Tue Jan 19 11:20am–11:50am De novo Design of Miniprotein Cytokine Mimics Targeting IL4Ra by Combining Diffusion Models, MD Simulations, and Phage Display Automation in Protein Discovery / Peptide Discovery & Engineering Predictive and AI-driven protein science Talk Tue Jan 19 2:30pm–3:00pm Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Automation in Protein Discovery Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Novo Nordisk Chair Wed Jan 20 8:15am–8:20am Chairperson's Remarks Peptide Discovery & Engineering Talk Wed Jan 20 9:35am–10:05am What Does the Future Hold for Antibody "Lab-in-the-Loop" Methods? Analytical Intelligence Talk Wed Jan 20 9:40am–10:05am Discovery and Characterization of Potent Macrocycle Inhibitors Peptide Discovery & Engineering Talk Wed Jan 20 3:00pm–3:30pm Overcoming in-Process Autolysis: A Robust Purification Strategy for Difficult-to-Purify Recombinant Peptidases Tools for Purification and Quality
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research.	Talk Mon Jan 18 10:00am–10:30am When Execution is No Longer the Bottleneck: Reimagining Design of Experiments for Predictive, Data-Driven Protein Production SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 9:10am–9:40am Implementing Agentic AI and Autonomous Systems in Analytical Development Analytical Intelligence Talk Tue Jan 19 9:40am–10:10am Discovery of an NRAS Isoform and Activation-State-Selective Macrocyclic Peptide Automation in Protein Discovery / Peptide Discovery & Engineering Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Analytical Intelligence Talk Wed Jan 20 11:10am–11:40am Modeling Stability to Support Biotherapeutics Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Tools for Purification and Quality Talk Wed Jan 20 3:00pm–3:30pm Investigation of Low Molecular Weight (LMW) Formation of a Multispecific Antibody by Protease Inhibitor Study Biophysical Methods and Models Talk Wed Jan 20 3:30pm–4:00pm Rapid Benchtop ¹H-NMR for Real-Time Monitoring of Purification Performance and Product Quality Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Scaling Formulation Development with 384-Well ELISA for Stability, Potency, and Process Monitoring Tools for Purification and Quality Talk Thu Jan 21 2:55pm–3:20pm Enabling Oral and Parenteral GLP-1 Delivery through Biophysical and Molecular Characterizations Peptide Therapeutics: Emerging Modalities & Development
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Jan 19 11:50am–12:20pm From Data Silos to Shared Insights: Democratizing Data and AI for Accelerated Biotherapeutics Analytics and Decision Making Analytical Intelligence Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm Predictive Accelerated Stability Studies: A Strategic Approach to Developing Oligonucleotide Therapeutics Biophysical Methods and Models
Novartis Basel, Switzerland
novartis.com Large pharma Swiss pharmaceutical company with antibody, peptide and other medicines across oncology, immunology, cardiovascular and neuroscience.	Talk Wed Jan 20 9:05am–9:35am Taking Smart Risks: Standardization, Digitalization, and Predictive Stability to Accelerate Analytical Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Biophysical Methods and Models Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Peptide Therapeutics: Emerging Modalities & Development Talk Wed Jan 20 5:10pm–5:40pm Clinical Pharmacology Perspectives on Immunogenicity of Peptide Drugs Peptide Therapeutics: Emerging Modalities & Development Panel Wed Jan 20 5:40pm–6:10pm Stick to the Science—How Evidence Generation Can Build upon Technology Enthusiasm to Advance Both Regulatory Certainty and Market Momentum Peptide Therapeutics: Emerging Modalities & Development · with U.S. Food and Drug Administration, U.S. Pharmacopeia, ELIQUENT Life Sciences Talk Thu Jan 21 8:40am–9:10am Predictive Models for Biophysical Developability Properties Biophysical Methods and Models
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Danish pharmaceutical company known for insulin and GLP-1 peptide medicines for diabetes and obesity, with protein and peptide discovery research.	Chair Tue Jan 19 4:20pm–4:25pm Chairperson's Remarks Plenary Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Prescient Design, Eli Lilly, Generate Biomedicines Predictive and AI-driven protein science Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Genentech Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Chugai Pharmaceutical +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Thu Jan 21 3:20pm–3:45pm From Molecule to Mucosa: Designing Better Peptide Delivery Systems Peptide Therapeutics: Emerging Modalities & Development
University of California, Santa Barbara Santa Barbara, CA
ucsb.edu Academic Public research university in the University of California system.	Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Opening Remarks Recombinant Protein Production - Part 2 Talk Thu Jan 21 9:40am–10:10am Developing an Anaerobic Cell-Free Protein Expression Platform Recombinant Protein Production - Part 2 Talk Thu Jan 21 9:40am–10:10am Development of Expedient Access to Functionalized Unnatural Amino Acids for Direct Peptide Synthesis Peptide Therapeutics: Emerging Modalities & Development
Chugai Pharmaceutical Tokyo, Japan
chugai-pharm.co.jp Large pharma Japanese pharmaceutical company in the Roche Group, known for antibody engineering and a mid-size cyclic peptide drug discovery program.	Talk Wed Jan 20 8:20am–8:50am From Undruggable to Druggable: Unlocking Intracellular PPIs with SnipeTide Technology Peptide Discovery & Engineering Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science